Cement-directing orthopedic implants
US-2016324558-A1 · Nov 10, 2016 · US
US10213309B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10213309-B2 |
| Application number | US-201615141394-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2016 |
| Priority date | Jun 25, 2003 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to orthopedic implants having a fenestrated hollow shell and a biologic core. These design features provide an improved interface between the implant and the surrounding tissue, aiding fixation, and provide a vehicle for applying new bone healing and enhancing modalities, such as gene therapy, tissue engineering, and growth factors.
Opening claim text (preview).
What is claimed is: 1. A musculo-skeletal implant comprising a first end having a vertebral-contacting surface to contact a first vertebra, a second end having a vertebral-contacting surface to contact a second vertebra, a longitudinal axis extending through respective centers of the first and second ends, an outer fenestrated wall extending from the first end to the second end, and a monolithic inner fenestrated wall inside the outer fenestrated wall and extending entirely around the longitudinal axis to laterally surround a central hollow cavity that extends through the first and second ends, wherein an open space extends through the first and second ends and between the inner fenestrated wall and the outer fenestrated wall from the first end to the second end, wherein fenestrations of the outer fenestrated wall extend toward the inner fenestrated wall and into the open space, wherein fenestrations of the inner fenestrated wall are arranged laterally around the longitudinal axis, wherein the open space extends through the first end to an outside of the implant via a plurality of individual openings each forming a shape with a different number of sides than at least one of the fenestrations of the inner or outer fenestrated walls, and wherein at least one linear pathway extends unobstructed from the hollow cavity through respective fenestrations of the inner and outer fenestrated walls to the outside of the implant, wherein the inner fenestrated wall is integrally connected with the outer fenestrated wall by a plurality of interconnecting members, wherein first ones of the interconnecting members located at an end face at the first end at least partially define the individual openings and have at least a portion that faces away from all other parts of the implant, while another one of the interconnecting members is spaced apart from the first and second ends, wherein at least two of the interconnecting members are aligned laterally around the longitudinal axis, and wherein a distance between the inner and outer fenestrated walls at one of the interconnecting members is substantially the same as a distance between the inner and outer fenestrated walls at a location between two laterally adjacent ones of the interconnecting members, and wherein the inner and outer fenestrated walls comprise a non-biodegradable material and are permanently fixable with a host body tissue by integration as a structural support of the inner and outer fenestrated walls therewith. 2. The musculo-skeletal implant of claim 1 , wherein the implant comprises at least one of titanium or a titanium alloy. 3. The musculo-skeletal implant of claim 1 , wherein the musculo-skeletal implant is a vertebral implant. 4. The musculo-skeletal implant of claim 1 , wherein the interconnecting members are oriented substantially in a radial direction transverse to the longitudinal axis. 5. The musculo-skeletal implant of claim 1 , wherein at least one of the interconnecting members is located substantially equidistant between the first end of the implant and the second end of the implant. 6. The musculo-skeletal implant of claim 1 , wherein the fenestrations of the outer fenestrated wall are diamond shaped. 7. The musculo-skeletal implant of claim 1 , wherein the outer fenestrated wall and the inner fenestrated wall are configured to concurrently contact a vertebra at the first end of the implant and to contact an adjacent vertebra at the second end of the implant. 8. The musculo-skeletal implant of claim 1 , wherein some of the interconnecting members are spaced apart axially from one another at a regular interval. 9. The musculo-skeletal implant of claim 1 , wherein the inner fenestrated wall and the outer fenestrated wall extend coaxially. 10. The musculo-skeletal implant of claim 1 , wherein the open space between the inner fenestrated wall and the outer fenestrated wall is filled with bone material. 11. The musculo-skeletal implant of claim 1 , further comprising a biologic core within the outer fenestrated wall. 12. The musculo-skeletal implant of claim 1 , wherein the inner fenestrated wall is positioned completely within the outer fenestrated wall. 13. The musculo-skeletal implant of claim 1 , wherein the outer fenestrated wall is exposed to permit contact with body tissue. 14. The musculo-skeletal implant of claim 1 , wherein at least one of the plurality of individual openings is formed at the first end of the implant. 15. The musculo-skeletal implant of claim 1 , wherein at least part of the inner or outer fenestrated walls is curved. 16. The musculo-skeletal implant of claim 1 , wherein at least one interconnecting member that defines the at least one linear pathway extends along a straight line from the inner fenestrated wall to the outer fenestrated wall. 17. The musculo-skeletal implant of claim 1 , wherein the outer fenestrated wall comprises at least one portion that extends continuously from the first end of the implant to the second end of the implant at a constant angle relative to a plane in which the end face at the first end extends. 18. The musculo-skeletal implant of claim 1 , wherein two fenestrations of the outer fenestrated wall are directly adjacent to one another and axially offset from one another, with each having top and bottom ends spaced apart from the longitudinal axis by substantially the same distance. 19. A musculo-skeletal implant comprising first and second ends each having a vertebral-contacting surface configured to contact respective vertebrae, a longitudinal axis extending through respective centers of the first and second ends, an outer fenestrated wall extending from the first end to the second end, and a monolithic inner fenestrated wall inside the outer fenestrated wall and extending entirely around the longitudinal axis to laterally surround a central hollow cavity that extends through the first and second ends, the outer and inner fenestrated walls each comprising a non-biodegradable material, wherein the inner fenestrated wall is integrally connected with the outer fenestrated wall by a plurality of interconnecting members, wherein first ones of the interconnecting members located at an end face at the first end each has at least a portion that faces away from all other parts of the implant, while another one of the interconnecting members is spaced apart from the first and second ends, wherein a first fenestration of the outer fenestrated wall and a first fenestration of the inner fenestrated wall form respective polygons with a same number of sides, such that a linear pathway having a shape corresponding to the respective polygons extends unobstructed from the hollow cavity through the respective first fenestrations of the inner and outer fenestrated walls to an outside of the implant, and wherein an open space extends between the inner and outer fenestrated walls and through the first and second ends, the open space extending through the first end to the outside of the implant via a plurality of individual openings that are at least partially defined by the first ones of the interconnecting members, each individual opening forming a shape with a different number of sides than the respective polygons formed by the first fenestrations of the inner and outer fenestrated walls. 20. The musculo-skeletal implant of claim 19 , wherein the implant comprises at least one of titanium or a titanium alloy. 21. The musculo-skeletal implant of claim 19 , wherein the musculo-skeletal implant is a vertebral impl
Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body · CPC title
for the spine, e.g. vertebrae, spinal discs · CPC title
Internal fixation devices {, including fasteners and spinal fixators, even if a part thereof projects from the skin (bone staples A61B17/0642)} · CPC title
with a threaded, e.g. self-tapping, bone-engaging surface, e.g. external surface · CPC title
Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.